Strength
200 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378267001
Classification
Brand (ANDA)
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
PHENYTOIN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA040298On Market Since
12/10/2001
Pharmacological Classes
Anti-epileptic Agent
Cytochrome P450 1A2 Inducers
Cytochrome P450 2B6 Inducers
Cytochrome P450 2C19 Inducers
Cytochrome P450 2C8 Inducers
Cytochrome P450 2C9 Inducers
Cytochrome P450 2D6 Inducers
Cytochrome P450 3A Inducers
Decreased Central Nervous System Disorganized Electrical Activity
Related Drugs
Same classification
DILANTIN 30 MG CAPSULE
Brand
58151011801•Viatris Specialty LLC
$1.4971
per EA
DILANTIN 50 MG INFATAB
Brand
00071000724•Pfizer Inc.
$1.5818
per EA
DILANTIN 100 MG CAPSULE
Brand
00071036932•Pfizer Inc.
$1.7420
per EA
DILANTIN 100 MG CAPSULE
Brand
58151011001•Viatris Specialty LLC
$1.7420
per EA
DILANTIN 100 MG CAPSULE
Brand
58151011088•Viatris Specialty LLC
$1.7420
per EA
PHENYTEK 300 MG CAPSULE
Brand
00378375001•Mylan Pharmaceuticals Inc.
$2.0925
per EA
PHENYTEK 300 MG CAPSULE
Brand
00378375093•Mylan Pharmaceuticals Inc.
$2.0925
per EA
GABARONE 400 MG TABLET
Brand
74157011190•INA Pharmaceutics Inc.
$8.5689
per EA
GABARONE 100 MG TABLET
Brand
74157001390•INA Pharmaceutics Inc.
$8.7130
per EA